Skip to Main Content

Author Details

Sana D Karam
University of Colorado School of Medicine
2000
137
29
PMIDPaper TitleJournal TitlePublished Year
36698398Canine oral squamous cell carcinoma as a spontaneous, translational model for radiation and immunology research.Front Oncol2023
37491456Measurement of mouse head and neck tumors by automated analysis of CBCT images.Sci Rep2023
37586327Selective targeting of IL2Rβγ combined with radiotherapy triggers CD8- and NK-mediated immunity, abrogating metastasis in HNSCC.Cell Rep Med2023
35680415Lack of Adherence to Guideline-Based Imaging Before Subsequent Radiation in Patients with Non-Small Cell Lung Cancer: Impact on Patient Outcomes.J Nucl Med2023
35596706Revisiting laminin and extracellular matrix remodeling in metastatic squamous cell carcinoma: What have we learned after more than four decades of research?Mol Carcinog2023
37124531A novel preclinical model of craniospinal irradiation in pediatric diffuse midline glioma demonstrates decreased metastatic disease.Front Oncol2023
37053041Short-term topiramate treatment prevents radiation-induced cytotoxic edema in preclinical models of breast-cancer brain metastasis.Neuro Oncol2023
37116489Simultaneous targeting of PD-1 and IL-2Rβγ with radiation therapy inhibits pancreatic cancer growth and metastasis.Cancer Cell2023
37363104Updates on radiotherapy-immunotherapy combinations: Proceedings of 6<sup>th</sup> annual ImmunoRad conference.Oncoimmunology2023
36747867Rapid PTEFb-dependent transcriptional reorganization underpins the glioma adaptive response to radiotherapy.bioRxiv2023
36918130Phase 1 Dose Escalation Study of SBRT Using 3 Fractions for Locally Advanced Pancreatic Cancer.Int J Radiat Oncol Biol Phys2023
36577897Author Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.Nat Cancer2023
36599398Vasculitis, CA19-9, and Perineural Invasion Differentially Predict Response and Surgical Outcome in Pancreatic Ductal Adenocarcinoma.Int J Radiat Oncol Biol Phys2023
36824740Short-term Topiramate treatment prevents radiation-induced cytotoxic edema in preclinical models of breast-cancer brain metastasis.bioRxiv2023
36563300Treatment outcomes and cost comparisons for older adults with T4 laryngeal squamous cell cancer.Head Neck2023
34559306Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma.Cancer Immunol Immunother2022
35605559The role of concomitant chemoradiotherapy versus radiation alone in T1-3N0 HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.Oral Oncol2022
35725568EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment.Nat Commun2022
36434392A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.Nat Cancer2022
36338745Population-level and individual-level explainers for propensity score matching in observational studies.Front Oncol2022
36064748Guided imagery for treatment (GIFT): protocol of a pilot trial of guided imagery versus treatment as usual to address radiotherapy-related distress in head and neck cancer.Pilot Feasibility Stud2022
36196859The impact of operability status on outcomes in patients with T4 larynx cancer undergoing larynx preservation.Head Neck2022
36385142Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors.Nat Commun2022
35136963Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis.Br J Surg2022
34862244Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma.Clin Cancer Res2022
34793974Dichotomous effects of cellular expression of STAT3 on tumor growth of HNSCC.Mol Ther2022
34610386Therapeutic Intervention Using a Smad7-Based Tat Protein to Treat Radiation-Induced Oral Mucositis.Int J Radiat Oncol Biol Phys2022
34570920Amateur antigen-presenting cells in the tumor microenvironment.Mol Carcinog2022
33119176Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer.Cancer2021
33883256Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis.J Immunother Cancer2021
33910002Transcriptional control of DNA repair networks by CDK7 regulates sensitivity to radiation in MYC-driven medulloblastoma.Cell Rep2021
33516431Immunotherapy in Head and Neck Cancer-Ready for Prime Time or More Research Needed?Int J Radiat Oncol Biol Phys2021
33789881Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer.J Immunother Cancer2021
33485341Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response.J Transl Med2021
33530388Light-Responsive Polymeric Micellar Nanoparticles with Enhanced Formulation Stability.Polymers (Basel)2021
33887515Metrics of pN-staging in oral squamous cell carcinoma: An analysis of 1,905 patients.Eur J Cancer2021
33526513Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer.Cancer Res2021
34885187Multimodality Management of EBV-Associated Nasopharyngeal Carcinoma.Cancers (Basel)2021
34382714Outcomes between intensity-modulated radiation therapy versus 3D-conformal in early stage glottic cancer.Head Neck2021
34433873Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFβ/PD-L1 blockade-treated squamous cell carcinoma.Commun Biol2021
34518311FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC.Clin Cancer Res2021
34544797IL13Rα2 Promotes Proliferation and Outgrowth of Breast Cancer Brain Metastases.Clin Cancer Res2021
34277390Overcoming Resistance to Immunotherapy in Head and Neck Cancer Using Radiation: A Review.Front Oncol2021
34155509Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study.Br J Surg2021
34013577Factors predictive of 90-day mortality after surgical resection for oral cavity cancer: Development of a recursive partitioning analysis for risk stratification.Head Neck2021
34289190Survival impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in head and neck cancer.Head Neck2021
33097963Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide.Cancer Immunol Immunother2021
30977524Epidemiology and treatment trends for primary tracheal squamous cell carcinoma.Laryngoscope2020
32858811Tuberculosis-Cancer Parallels in Immune Response Regulation.Int J Mol Sci2020
32629082Deciphering the Intricate Roles of Radiation Therapy and Complement Activation in Cancer.Int J Radiat Oncol Biol Phys2020
  • 1 - 50 of 137

Recommended Authors

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
Career Start Year 2016
Number of shared co-authors 1
Princess Margaret Cancer Center
Career Start Year 2015
Number of shared co-authors 5
Stanford University
Career Start Year 2014
Number of shared co-authors 1
Medical College of Wisconsin
Career Start Year 2013
Number of shared co-authors 3
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 2
Mayo Clinic
Career Start Year 2008
Number of shared co-authors 6
University of California San Diego Health
Career Start Year 2008
Number of shared co-authors 1
George Washington University
Career Start Year 2007
Number of shared co-authors 2
University of California los angeles
Career Start Year 2007
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 6
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2001
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 6
university of california san diego Health System
Career Start Year 2001
Number of shared co-authors 5
University of Western Ontario
Career Start Year 2001
Number of shared co-authors 4
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 7
Johns Hopkins University
Career Start Year 2000
Number of shared co-authors 3
University of Western Ontario
Career Start Year 2000
Number of shared co-authors 4
Stanford University
Career Start Year 1999
Number of shared co-authors 5
Memorial Sloan Kettering Cancer Center
Career Start Year 1999
Number of shared co-authors 6
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 7
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 2
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 8
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 3
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 8
Brigham and Women's Hospital
Career Start Year 1988
Number of shared co-authors 2
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 7
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year 1987
Number of shared co-authors 5
MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 8
Memorial Sloan Kettering Cancer Center
Career Start Year 1987
Number of shared co-authors 8

Collaborators

University of Colorado Denver at Anschutz Medical Campus
Co-authored papers 33
Universite de Sherbrooke
Co-authored papers 29
University of Colorado
Co-authored papers 23
University of Colorado Denver at Anschutz Medical Campus
Co-authored papers 21
University of Colorado School of Medicine
Co-authored papers 13
Sidney Kimmel Cancer Center at Thomas Jefferson University
Co-authored papers 13
University of Colorado Anschutz Medical Campus
Co-authored papers 12
University of Colorado
Co-authored papers 9
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 7
Mount Sinai Hospital
Co-authored papers 7
University of Colorado
Co-authored papers 6
University of Colorado School of Medicine
Co-authored papers 6
Center for Cancer and Blood Disorders, Children's Hospital Colorado.
Co-authored papers 6
Co-authored papers 5
University of Colorado Anschutz Medical Campus
Co-authored papers 5
University of Colorado Anschutz Medical Campus
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
University of Colorado Anschutz Medical Campus
Co-authored papers 4
National Cancer Centre Singapore
Co-authored papers 4
Center for Innovative Design and Analysis, University of Colorado, Aurora CO.
Co-authored papers 3
Co-authored papers 3
Vanderbilt University School of Medicine
Co-authored papers 3
University of Colorado Anschutz Medical Campus
Co-authored papers 3
University of Colorado Denver
Co-authored papers 3
University of Colorado Anschutz Medical Campus
Co-authored papers 3
University of Colorado
Co-authored papers 3
University of Colorado Denver
Co-authored papers 3
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Brain Tumor Institute, Children's National Hospital
Co-authored papers 3